ESCMID Study Group for Infections in Compromised Hosts - ESGICH
News & Activities
- 31 March, 8.45-10.45
Educational Workshop EW01 "State-of-the-art management of infections following solid organ transplantation"
Jointly arranged with ESGICH and EFISG - 31 March, 11.00-13.00
Educational Workshop EW15 "Febrile neutropenia - past, present and future"
Arranged with ESGICH and the European Organisation for Research and Treatment of Cancer (EORTC)
- 2 April, 11.30-12.30
1-hour Symposium "Immunotherapy after transplantation: the present, the future" - 2 April, 13.00-14.00 (Meeting Room 5/6)
ESGICH Business Meeting
Minutes
For more details, please check the ECCMID programme.
Infections in Immunocompromised Hosts
ESGICH co-organised this ESCMID Conference in Istanbul, Turkey, 17 - 18 November 2011.
ESGICH study - thank you for your involvement
Dear colleague, as an expert in Infectious Diseases on transplantation I would like to present you a new research project developed by the Spanish Network for Research in Infectious Diseases (REIPI). This project is aimed to know the role of prophylaxis against tuberculosis in patients with liver transplantation.
Your participation
Questionnaire (to be returned by 1 September 2011)
Please complete this questionnaire assessing the degree of your interest in such a study.
Background
As you know the decision to use prophylaxis with isoniazid in these patients is hampered by its hepatotoxicity. For this reason we have developed a study that compare the usual prophylaxis with isoniazid with levofloxacin, a drug presumably less toxic at least as effective as isoniazid. The project is entitled: “Prospective, randomized, comparative study of the effectiveness and safety of levofloxacino vs. isoniazid in the treatment of latent tuberculosis infection of liver transplant recipients” (Protocol: FLISH-ILT. EudraCT number: 2010-022302-41).
This Project will be done with the collaboration of the Spanish Clinical Research Network (CAIBER) that offer to the biomedical researchers its infrastructure and its multiples resources to promote multicenter, safe, rigorous and controlled clinical trials, guaranteed to preserve the quality of the clinical trial, the patient safety and the reliability of the data. This public consortium depends on the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III (ISCIII), and it includes 40 hospitals, public and private in order to coordinate and finance national and international clinical trials. Please consult its website for further information.
CAIBER is integrated into the European Clinical Research Infrastructure Network (ECRIN), that is involved in the development of clinical multinational multicenter research projects in Europe and worldwide. As part of this European activity our objective is to present this project to the Seventh Framework Programme's (FP7) into the topic FP7-2012.2.3.2-2 Comorbidity between infectious and non-communicable diseases. The announcement of the FP7 program is done into two phases and the deadline for the presentation of new projects is 4 October 2011. The EU contribution limit is 6,000,000 €.
At the top of the page, you find a questionnaire which contains the most important study characteristics to be carried out and an assessment of the degree of interest of researchers in the study.
With indicating your interest in participating in the project through the questionnaire, you will receive a complete copy of the protocol for your evaluation.
Given the complexity of the process of applying for a research project to the Seventh Framework Programme (FP7) I beg you to complete the questionnaire as soon as possible. Please don’t hesitate to ask me any question or doubt you may have on this project.
I think this is a great opportunity to establish a stable European clinical research structure to face and accomplish ambitious projects like this that, otherwise, would be impossible to run by individual groups.
Jose M Aguado MD, PhD
Chief, Unit of Infectious Diseases
University Hospital 12 de Octubre
Av. De Andalucia km 5,400
28041 Madrid, Spain
- 9 May, 18.15-19.15 (Room White 2)
ESGICH Business Meeting
All interested persons are cordially invited to join the meeting and plan future ESGICH activities.
For more details about the congress, please check the ECCMID/ICC programme.
Planned Activities
Educational
- Co-organisation of a meeting on infections in solid organ transplant recipients, 2010, Varese, Italy, organised by Paolo Grossi
- Planning of the ESCMID Conference on infections in the immunocompromised host, 17 – 18 November 2011, Istanbul, Turkey
Research Ideas
- Planned project on resistance patterns in haematological wards: a survey of cases of bacteraemia in haematological patients (or in allogeneic SCT patients)
Medical Guidelines
- Joint initiative with ECIL (European Conference on Infection in Leukemia) for a new guideline on the management of febrile neutropenia (meeting planned for September 2011)
- Guidelines for perioperative prophylaxis in solid organ transplantation
- Guidelines for the management of EBV infection and PTLD in solid organ transplant recipients
- Guidelines for prevention of donor-related infections in solid organ transplant recipients
